We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 368

Trade Secrets Made Practical - Part 2
  • Gowling WLG
  • Canada
  • September 15 2017

In a series of articles devoted to trade secrets, Gowling WLG professionals share their knowledge to help you understand and manage trade secrets to


Government of Canada finalizes amended NOC Regulations and new CSP Regulations
  • Gowling WLG
  • Canada
  • September 11 2017

The Government of Canada has finalized the Certificate of Supplementary Protection Regulations (the "CSP Regulations") and the amended Patented


Canada’s patented medicines regime: Trending upward and onward
  • Gowling WLG
  • Canada
  • August 1 2017

On July 14, 2017, Health Canada released the Therapeutic Products Directorate Statistical Report 20162017 for the Patented Medicines (Notice of


Draft Patent Rules released for public consultation: Overview of key changes
  • Gowling WLG
  • Canada
  • August 1 2017

The Canadian Intellectual Property Office (CIPO) has released draft revisions to the Patent Rules for public consultation. The draft revisions


Certificates of supplementary protection: Canada’s new sui generis patent term restoration regime
  • Gowling WLG
  • Canada
  • July 24 2017

We previously reported on Bill C-30 (the “Act to implement CETA”) which made important changes to Canada’s intellectual property landscape reflecting


Curtain lifted on proposed amended PM(NOC) Regulations
  • Gowling WLG
  • Canada
  • July 17 2017

The curtain has been lifted to reveal the proposed amendments to the Patented Medicines (Notice of Compliance) Regulations (the “Amended


$644 million patent infringement judgment is largest in Canadian history
  • Gowling WLG
  • Canada
  • July 11 2017

In its decision in The Dow Chemical Company v. Nova Chemicals Corporation, 2017 FC 637, the Federal Court of Canada has awarded the successful


Supreme Court of Canada rejects the Promise of the Patent Doctrine
  • Gowling WLG
  • Canada
  • June 30 2017

The Supreme Court of Canada released on June 30, 2017 its long-awaited decision (available here) addressing the issue of the "promise of the patent


Supreme Court of Canada Bulletin - June 30, 2017
  • Gowling WLG
  • Canada
  • June 30 2017

On appeal from a judgment of the Federal Court of Appeal (2015 FCA 158) affirming a decision of Rennie J. (2014 FC 638


Patent exhaustion in Canada and the UK
  • Gowling WLG
  • Canada, European Union, United Kingdom
  • June 12 2017

The doctrine of “patent exhaustion” provides that once a patentee sells one of its products, it can no longer exercise control over the specific